74 related articles for article (PubMed ID: 23525991)
21. The use of botulinum toxin A injection for the management of external sphincter dyssynergia in neurologically normal children.
Franco I; Landau-Dyer L; Isom-Batz G; Collett T; Reda EF
J Urol; 2007 Oct; 178(4 Pt 2):1775-9; discussion 1779-80. PubMed ID: 17707430
[TBL] [Abstract][Full Text] [Related]
22. Velopharyngeal dysfunction following botulinum toxin type A injection to the lateral pterygoid muscles for recurrent jaw dislocation.
Kanbour A; Hurrell MJL; Ricciardo P
BMJ Case Rep; 2021 Apr; 14(4):. PubMed ID: 33888473
[TBL] [Abstract][Full Text] [Related]
23. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
[TBL] [Abstract][Full Text] [Related]
24. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
25. Type A botulinum toxin in the treatment of chronic facial pain associated with temporo-mandibular dysfunction.
von Lindern JJ
Acta Neurol Belg; 2001 Mar; 101(1):39-41. PubMed ID: 11379274
[TBL] [Abstract][Full Text] [Related]
26. Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity.
Karsenty G; Reitz A; Lindemann G; Boy S; Schurch B
Urology; 2006 Dec; 68(6):1193-7. PubMed ID: 17141831
[TBL] [Abstract][Full Text] [Related]
27. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
[TBL] [Abstract][Full Text] [Related]
28. The Role of Botulinum Toxin A in Treatment of Temporomandibular Joint Disorders: A Review.
Ataran R; Bahramian A; Jamali Z; Pishahang V; Sadeghi Barzegani H; Sarbakhsh P; Yazdani J
J Dent (Shiraz); 2017 Sep; 18(3):157-164. PubMed ID: 29034269
[TBL] [Abstract][Full Text] [Related]
29. [Treatment of recurrent dislocation of the temporomandibular joint with botulinum toxin: an alternative approach].
Kotimäki J; Saarinen A
Duodecim; 2011; 127(19):2088-91. PubMed ID: 22073541
[TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.
Kolbasnik J; Waterfall WE; Fachnie B; Chen Y; Tougas G
Am J Gastroenterol; 1999 Dec; 94(12):3434-9. PubMed ID: 10606299
[TBL] [Abstract][Full Text] [Related]
31. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.
Schmid DM; Sauermann P; Werner M; Schuessler B; Blick N; Muentener M; Strebel RT; Perucchini D; Scheiner D; Schaer G; John H; Reitz A; Hauri D; Schurch B
J Urol; 2006 Jul; 176(1):177-85. PubMed ID: 16753396
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic use of botulinum A toxin in neurology].
Schnider P; Schmied M; Berger T; Auff E
Wien Klin Wochenschr; 1994; 106(11):335-44. PubMed ID: 8053201
[TBL] [Abstract][Full Text] [Related]
33. Repeated botulinum-A toxin injections in treatment of children with neurogenic detrusor overactivity.
Schulte-Baukloh H; Knispel HH; Stolze T; Weiss C; Michael T; Miller K
Urology; 2005 Oct; 66(4):865-70; discussion 870. PubMed ID: 16230156
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic effects of suburothelial injection of botulinum a toxin for neurogenic detrusor overactivity due to chronic cerebrovascular accident and spinal cord lesions.
Kuo HC
Urology; 2006 Feb; 67(2):232-6. PubMed ID: 16442605
[TBL] [Abstract][Full Text] [Related]
35. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A for the management of vulvodynia.
Yoon H; Chung WS; Shim BS
Int J Impot Res; 2007; 19(1):84-7. PubMed ID: 16728964
[TBL] [Abstract][Full Text] [Related]
37. Effect of botulinum toxin injection for achalasia in Thai patients.
Leelakusolvong S; Sinpeng T; Pongprasobchai S; Tanwandee T; Kachintorn U; Manatsathit S
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S67-72. PubMed ID: 17718248
[TBL] [Abstract][Full Text] [Related]
38. Treatment of detrusor-sphincter dyssynergia with botulinum A toxin: a double-blind study.
Dykstra DD; Sidi AA
Arch Phys Med Rehabil; 1990 Jan; 71(1):24-6. PubMed ID: 2297305
[TBL] [Abstract][Full Text] [Related]
39. Temporomandibular joint dislocation during orotracheal extubation.
Wang LK; Lin MC; Yeh FC; Chen YH
Acta Anaesthesiol Taiwan; 2009 Dec; 47(4):200-3. PubMed ID: 20015821
[TBL] [Abstract][Full Text] [Related]
40. Temporomandibular joint dislocation due to acute propranolol intoxication.
Aghabiklooei A; Elahi H; Mostafazadeh B
Int Med Case Rep J; 2010; 3():59-61. PubMed ID: 23754890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
